These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 7839975)

  • 1. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
    Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW
    AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doppler sonography of adnexal masses: the predictive value of the pulsatility index in benign and malignant disease.
    Salem S; White LM; Lai J
    AJR Am J Roentgenol; 1994 Nov; 163(5):1147-50. PubMed ID: 7976891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone.
    Buy JN; Ghossain MA; Hugol D; Hassen K; Sciot C; Truc JB; Poitout P; Vadrot D
    AJR Am J Roentgenol; 1996 Feb; 166(2):385-93. PubMed ID: 8553953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses.
    Valentin L
    Ultrasound Obstet Gynecol; 1999 Oct; 14(4):273-83. PubMed ID: 10586480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of adnexal masses with endovaginal gray-scale and duplex and color Doppler US: correlation with pathologic findings.
    Jain KA
    Radiology; 1994 Apr; 191(1):63-7. PubMed ID: 8134599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Eur J Gynaecol Oncol; 1996; 17(1):29-35. PubMed ID: 8750512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses.
    Antonić J; Rakar S
    Anticancer Res; 1995; 15(4):1527-32. PubMed ID: 7654041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features.
    Brown DL; Doubilet PM; Miller FH; Frates MC; Laing FC; DiSalvo DN; Benson CB; Lerner MH
    Radiology; 1998 Jul; 208(1):103-10. PubMed ID: 9646799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Power Doppler vascularity index for predicting malignancy of adnexal masses.
    Marret H; Sauget S; Giraudeau B; Body G; Tranquart F
    Ultrasound Obstet Gynecol; 2005 May; 25(5):508-13. PubMed ID: 15846763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical analysis of Doppler velocimetry in the differential diagnosis of malignant and benign ovarian masses.
    Marchesini AC; Magrio FA; Berezowski AT; Neto OB; Nogueira AA; Candido dos Reis FJ
    J Womens Health (Larchmt); 2008; 17(1):97-102. PubMed ID: 18240986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple ultrasound-based rules for the diagnosis of ovarian cancer.
    Timmerman D; Testa AC; Bourne T; Ameye L; Jurkovic D; Van Holsbeke C; Paladini D; Van Calster B; Vergote I; Van Huffel S; Valentin L
    Ultrasound Obstet Gynecol; 2008 Jun; 31(6):681-90. PubMed ID: 18504770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of benign and malignant adnexal masses: value of a morphologic scoring system.
    Topuz S; Saygili H; Akhan S; Yavuz E; Turfanda A; Berkman S
    Eur J Gynaecol Oncol; 2005; 26(2):209-12. PubMed ID: 15857033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow characteristics in benign and malignant gynecologic tumors using transvaginal color flow Doppler.
    Carter J; Saltzman A; Hartenbach E; Fowler J; Carson L; Twiggs LB
    Obstet Gynecol; 1994 Jan; 83(1):125-30. PubMed ID: 8272293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvaginal color Doppler assessment of venous flow in adnexal masses.
    Alcázar JL; López-García G
    Ultrasound Obstet Gynecol; 2001 May; 17(5):434-8. PubMed ID: 11380970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian masses: can benign and malignant lesions be differentiated with color and pulsed Doppler US?
    Brown DL; Frates MC; Laing FC; DiSalvo DN; Doubilet PM; Benson CB; Waitzkin ED; Muto MG
    Radiology; 1994 Feb; 190(2):333-6. PubMed ID: 8284377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvaginal color Doppler sonography of adnexal masses: differences in blood flow impedance in benign and malignant lesions.
    Hamper UM; Sheth S; Abbas FM; Rosenshein NB; Aronson D; Kurman RJ
    AJR Am J Roentgenol; 1993 Jun; 160(6):1225-8. PubMed ID: 8498222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transvaginal color Doppler ultrasonography and CA-125 in suspicious adnexal masses.
    Alcázar JL; Errasti T; Zornoza A; Mínguez JA; Galán MJ
    Int J Gynaecol Obstet; 1999 Sep; 66(3):255-61. PubMed ID: 10580673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of resistive index for the diagnosis of malignant ovarian masses.
    Majeed H; Ramzan A; Imran F; Mahfooz-ur-Rehman
    J Pak Med Assoc; 2011 Nov; 61(11):1104-7. PubMed ID: 22125988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.